Headquartered in Columbus Ohio with Lab Facilites in Athen OH, AEIOU Scientific is tackling improving the diagnosis of osteroporisis by addressing measurment in vivo mechanics of bone rather than bone mineral density disgnated by the firm as Cortical Bone Mechanics Technology (CBMT). Developing CBMT will shift the paradigm of clinical bone research and (later) clinical practice for bone disease from bone mineral to bone mechanics by enabling the mechanical properties of cortical bone to be measured in vivo. The firm argues that this non-invasive, non-significant risk device could enable investigators to characterize the distribution of cortical bone mass, stiffness, damping, and strength in the human population, and to study the effects of various diseases and interventions on these properties. Further that. depending on the outcome of their efforts and subsequent FDA approval of a medical device, CBMT could also perhaps enable physicians better to identify which patients to treat to prevent low-trauma fractures. if implemented, this approach could reduce the cost and hazard of unnecessary preventive care as well as the cost, pain and disability resulting from fractures in patients who do not currently receive needed preventive care.
